Nemzeti Dialízis Központ Kecskemét
- Address
- Nyíri út 38., 6000 Kecskemét, Hungary
Nemzeti Dialízis Központ Kecskemét - Advanced Dialysis and Cardiovascular Research
Nemzeti Dialízis Központ Kecskemét is a specialized dialysis center dedicated to advancing treatment options for patients with end-stage kidney disease (ESKD). The center focuses on investigating novel therapeutic approaches that address not only renal failure but also the complex cardiovascular complications that frequently affect dialysis patients.
- End-stage kidney disease (ESKD) management and maintenance dialysis optimization
- Cardiovascular disease prevention and treatment in dialysis populations
- Anti-inflammatory therapies targeting C-reactive protein reduction in renal patients
The center participates in cutting-edge clinical research evaluating innovative biological therapies such as clazakizumab (CSL300), focusing on reducing inflammatory markers and improving cardiovascular outcomes in patients undergoing chronic dialysis. Through their participation in dose-finding and outcomes studies, the center contributes valuable data to understanding how targeted interventions can address atherosclerotic cardiovascular disease in the vulnerable ESKD population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1CSL Behring LLC1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Nemzeti Dialízis Központ Kecskemét
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects with End Stage Kidney Disease Undergoing Dialysis | CSL Behring LLC | Phase IV | Recruiting | Jul 2023 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clazakizumab | 1 | Unknown | 2023-07-17 | 2023-07-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.